These results revealed that disruption of the clock gene Bmal1 may be one of the underlying mechanisms contributing to diabetic cardiomyopathy, and this finding may provide a potential therapeutic target for reducing hyperglycemia cardiotoxicity. Here, CLOCK is linked to Hyperglycemia.